Interest in the potential therapeutic benefits of psychedelic agents has recently increased. In addition to psilocybin, a wide variety of agents with psychedelic properties have been proposed and partially tested. However, the challenges of obtaining approval to market a restricted psychotomimetic agent are formidable.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/cpt.776 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!